95 related articles for article (PubMed ID: 6230536)
41. Nocturnal acid breakthrough in subjects taking PPI b.i.d.
Savarino V; Mela GS; Vigneri S
Am J Gastroenterol; 1999 Feb; 94(2):536-7. PubMed ID: 10022667
[No Abstract] [Full Text] [Related]
42. [Advances in the knowledge of peptic-acid dependent diseases].
Mazure PA; Pigliacampo J
Acta Gastroenterol Latinoam; 1989; 19(3):165-73. PubMed ID: 2576850
[No Abstract] [Full Text] [Related]
43. [Long-term results of the conservative treatment of patients with peptic ulcer].
Illarionov IuA; Dudnik SP; Pokhil'ko ND; Iarosh VN
Vrach Delo; 1983 Jan; (1):55-6. PubMed ID: 6868500
[No Abstract] [Full Text] [Related]
44. [Experience of application of Esomeprazole in patients with chronic hepatic diseases associated with acid-dependent diseases].
Ivanikov IO; Siutkin VE; Konstantinova TD
Eksp Klin Gastroenterol; 2004; (2):33-4, 109. PubMed ID: 15462317
[TBL] [Abstract][Full Text] [Related]
45. Physiology of gastric acid secretion.
Zermansky A
Lancet; 1997 Aug; 350(9075):447. PubMed ID: 9259683
[No Abstract] [Full Text] [Related]
46. Caution and patient safety concerns should guide us.
Fraser GL; Riker RR
Crit Care Med; 2005 Feb; 33(2):471-2; author reply 472. PubMed ID: 15699880
[No Abstract] [Full Text] [Related]
47. [A double-blind short-term clinical trial of furazolidone on peptic ulcer].
Zheng ZT
Zhonghua Nei Ke Za Zhi; 1984 Apr; 23(4):195-7. PubMed ID: 6386383
[No Abstract] [Full Text] [Related]
48. Therapeutic progress--review XXIV. Are we making progress? The treatment of peptic ulcer disease by control of gastric acidity.
Reed PI; McIsaac RL
J Clin Pharm Ther; 1987 Apr; 12(2):71-80. PubMed ID: 3294867
[No Abstract] [Full Text] [Related]
49. Omeprazole suppresses endothelial calcium response and eNOS Ser1177 phosphorylation in porcine aortic endothelial cells.
Kamiya C; Odagiri K; Hakamata A; Sakurada R; Inui N; Watanabe H
Mol Biol Rep; 2021 Jul; 48(7):5503-5511. PubMed ID: 34291395
[TBL] [Abstract][Full Text] [Related]
50.
Zhang M; Yu W; Zhou S; Zhang B; Lo ECM; Xu X; Zhang D
Front Microbiol; 2021; 12():647611. PubMed ID: 33717046
[TBL] [Abstract][Full Text] [Related]
51. Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy.
Savarino V; Mela GS; Zentilin P; Cutela P; Mele MR; Vigneri S; Celle G
Dig Dis Sci; 1994 Jan; 39(1):161-8. PubMed ID: 8281852
[TBL] [Abstract][Full Text] [Related]
52. The pathophysiology of peptic ulcer disease.
Brooks FP
Dig Dis Sci; 1985 Nov; 30(11 Suppl):15S-29S. PubMed ID: 4053922
[TBL] [Abstract][Full Text] [Related]
53. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
Clissold SP; Campoli-Richards DM
Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
[TBL] [Abstract][Full Text] [Related]
54. Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial.
Lauritsen K; Rune SJ; Wulff HR; Olsen JH; Laursen LS; Havelund T; Astrup L; Bendtsen F; Linde J; Bytzer P
Gut; 1988 Feb; 29(2):249-53. PubMed ID: 3278955
[TBL] [Abstract][Full Text] [Related]
55. U.S. experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. The Omeprazole DU Comparative Study Group.
Valenzuela JE; Berlin RG; Snape WJ; Johnson TL; Hirschowitz BI; Colon-Pagan J; Morse RS; Petrozza J; Van Deventer GM; Cagliola A
Dig Dis Sci; 1991 Jun; 36(6):761-8. PubMed ID: 2032518
[TBL] [Abstract][Full Text] [Related]
56. Pump blockers and ulcer disease.
Sachs G
N Engl J Med; 1984 Mar; 310(12):785-6. PubMed ID: 6230536
[No Abstract] [Full Text] [Related]
57. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
McArthur KE; Jensen RT; Gardner JD
Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811
[TBL] [Abstract][Full Text] [Related]
58. [Omeprazole--a drug-blocking proton pump of the parietal cells of the stomach].
Sosnowski M
Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1469-72. PubMed ID: 3008128
[No Abstract] [Full Text] [Related]
59. Pharmacologic control of gastric acid secretion in peptic ulcer.
Konturek SJ
Mt Sinai J Med; 1983; 50(6):457-67. PubMed ID: 6141524
[No Abstract] [Full Text] [Related]
60. Treatment of ulcer disease.
Spenney JG
Ala J Med Sci; 1985 Jan; 22(1):49-53. PubMed ID: 3883827
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
